vitiligo

Dutch biopharma Argenx is acquiring Dallas-based Forte Biosciences for $2.2 billion. [Image: AdobeStock]

Forte Biosciences Acquired by Dutch Pharma Firm for $2.2B

by | Jul 28, 2026
The Dallas-based biopharma company focuses on treatment for autoimmune diseases.
MORE►
CAGE Bio Relocates Fort Worth Office to BioLabs at Pegasus Park in Dallas
by | Jul 15, 2025
The California-based clinical-stage biotech startup is developing therapies to treat serious immunological diseases like atopic dermatitis and vitiligo.
MORE►
A Special Thank you to our sponsors

Dallas Innovates is owned by the Dallas Regional Chamber. Editorial operations are led independently by Lawley Head Media.

© Copyright 2026 | All rights reserved.

Business

Creative

Education

Impact

Invention

Startup

Our Sponsors

Our Partners